Growth Metrics

Oculis Holding AG (OCS) Total Liabilities (2021 - 2026)

Quarterly Total Liabilities rose 30.84% to $60.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $60.5 million through Mar 2026, up 30.84% year-over-year, with the annual reading at $49.9 million for FY2025, 6.91% down from the prior year.

Oculis Holding AG's Total Liabilities history spans 6 years, with the latest figure at $60.5 million for Q1 2026.

  • Total Liabilities came in at $60.5 million for Q1 2026, up from $49.9 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $140.2 million in Q4 2022 to a low of $19.6 million in Q2 2023.
  • The 5-year median for Total Liabilities is $46.2 million (2025), against an average of $46.1 million.
  • Year-over-year, Total Liabilities tumbled 83.41% in 2023 and then surged 130.6% in 2024.
  • Oculis Holding AG's Total Liabilities stood at $140.2 million in 2022, then crashed by 83.41% to $23.3 million in 2023, then soared by 130.6% to $53.6 million in 2024, then dropped by 6.91% to $49.9 million in 2025, then grew by 21.13% to $60.5 million in 2026.
  • Per Business Quant, the three most recent readings for OCS's Total Liabilities are $60.5 million (Q1 2026), $49.9 million (Q4 2025), and $46.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 16.35 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 1.74 Mn
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 731.60 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 177.22 Mn
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 19.51 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 7.12 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 9.45 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - 10.44 Mn
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 4.05 Bn
10 Oculis Holding AG 24.51 Bn 24.21 Bn - 60.46 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 60.46 Mn
Dec 31, 2025 49.91 Mn
Sep 30, 2025 46.56 Mn
Jun 30, 2025 46.53 Mn
Mar 31, 2025 46.21 Mn
Dec 31, 2024 53.62 Mn
Sep 30, 2024 35.06 Mn
Jun 30, 2024 28.65 Mn
Mar 31, 2024 22.55 Mn
Dec 31, 2023 23.25 Mn
Sep 30, 2023 26.42 Mn
Jun 30, 2023 19.63 Mn
Dec 31, 2022 140.19 Mn
Dec 31, 2021 129.05 Mn